Infinity Pharmaceuticals Inc. (INFIQ)
OTCMKTS: INFIQ · Delayed Price · USD
0.00
0.00 (0.00%)
Apr 29, 2024, 2:51 PM EDT - Market open
Infinity Pharmaceuticals Revenue
Revenue in the quarter ending June 30, 2023 was $583.00K. In the year 2022, Infinity Pharmaceuticals had annual revenue of $2.59M with 39.56% growth.
Revenue (ttm)
$2.59M
Revenue Growth
+39.56%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
352.15K USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 2.59M | 735.00K | 39.56% |
| Dec 31, 2021 | 1.86M | 139.00K | 8.09% |
| Dec 31, 2020 | 1.72M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionINFIQ News
- 7 months ago - INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI - Business Wire
- 7 months ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the Firm - Accesswire
- 7 months ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 7 months ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the Firm - Accesswire
- 7 months ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 7 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI - PRNewsWire
- 7 months ago - DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the Firm - Accesswire
- 7 months ago - INFI IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI - PRNewsWire